NanoSphere Health Sciences Inc. (NSHS.CN)
CAD 0.06
(-7.69%)
CAD 0.06
(-7.69%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -220.07 Thousand USD | 99.92% |
| 2022 | -286 Thousand USD | 26.31% |
| 2021 | -388.08 Thousand USD | 28.12% |
| 2020 | -539.87 Thousand USD | 83.32% |
| 2019 | -3.23 Million USD | 29.66% |
| 2018 | -4.6 Million USD | -301.34% |
| 2017 | -1.14 Million USD | -84.31% |
| 2016 | -621.86 Thousand USD | -436.32% |
| 2015 | -115.95 Thousand USD | 34.98% |
| 2014 | -178.33 Thousand USD | 83.64% |
| 2013 | -1.08 Million USD | 57.72% |
| 2012 | -2.57 Million USD | 17.05% |
| 2011 | -3.1 Million USD | -1471.59% |
| 2010 | -197.71 Thousand USD | -27.82% |
| 2009 | -154.68 Thousand USD | 54.57% |
| 2008 | -340.52 Thousand USD | 70.72% |
| 2007 | -1.16 Million USD | -3632.9% |
| 2006 | -31.15 Thousand USD | -22.82% |
| 2005 | -25.36 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -22.73 Thousand USD | -39763.22% |
| 2024 Q2 | -56.71 Thousand USD | -129.04% |
| 2023 Q3 | -63.86 Thousand USD | -14.26% |
| 2023 Q2 | -55.89 Thousand USD | -3.68% |
| 2023 Q1 | -53.91 Thousand USD | 61.36% |
| 2023 Q4 | -57.03 USD | 99.91% |
| 2023 FY | -220.08 USD | 99.92% |
| 2022 Q2 | -61.57 Thousand USD | 22.46% |
| 2022 FY | -286 Thousand USD | 26.31% |
| 2022 Q4 | -139.53 Thousand USD | -1005.51% |
| 2022 Q3 | 15.41 Thousand USD | 125.03% |
| 2022 Q1 | -79.4 Thousand USD | 10.17% |
| 2021 FY | -388.08 Thousand USD | 28.12% |
| 2021 Q1 | -69.79 Thousand USD | 55.01% |
| 2021 Q2 | -145.9 Thousand USD | -109.05% |
| 2021 Q3 | -81.91 Thousand USD | 43.86% |
| 2021 Q4 | -88.39 Thousand USD | -7.92% |
| 2020 Q1 | -226.63 Thousand USD | 79.77% |
| 2020 Q2 | -115.69 Thousand USD | 48.95% |
| 2020 Q3 | -68.15 Thousand USD | 41.09% |
| 2020 Q4 | -155.13 Thousand USD | -127.62% |
| 2020 FY | -539.87 Thousand USD | 83.32% |
| 2019 FY | -3.23 Million USD | 29.66% |
| 2019 Q4 | -1.12 Million USD | -29.89% |
| 2019 Q3 | -862.34 Thousand USD | -65.55% |
| 2019 Q2 | -520.89 Thousand USD | 29.58% |
| 2019 Q1 | -739.72 Thousand USD | 64.29% |
| 2018 Q2 | -813.38 Thousand USD | 18.51% |
| 2018 FY | -4.6 Million USD | -301.34% |
| 2018 Q4 | -2.07 Million USD | -188.72% |
| 2018 Q3 | -717.38 Thousand USD | 11.8% |
| 2018 Q1 | -998.12 Thousand USD | -18.54% |
| 2017 Q1 | -73.72 Thousand USD | 12.29% |
| 2017 FY | -1.14 Million USD | -84.31% |
| 2017 Q4 | -842 Thousand USD | -848.31% |
| 2017 Q3 | -88.78 Thousand USD | 31.63% |
| 2017 Q2 | -129.85 Thousand USD | -76.15% |
| 2016 Q1 | -24.58 Thousand USD | -2.5% |
| 2016 FY | -621.86 Thousand USD | -436.32% |
| 2016 Q3 | -464.73 Thousand USD | -836.89% |
| 2016 Q2 | -49.6 Thousand USD | -101.75% |
| 2016 Q4 | -84.05 Thousand USD | 81.91% |
| 2015 Q2 | -40.35 Thousand USD | -21.83% |
| 2015 Q4 | -23.98 Thousand USD | -2.6% |
| 2015 Q3 | -23.37 Thousand USD | 42.06% |
| 2015 FY | -115.95 Thousand USD | 34.98% |
| 2015 Q1 | -33.11 Thousand USD | -118.76% |
| 2014 Q4 | 176.56 Thousand USD | 174.48% |
| 2014 Q1 | -56.81 Thousand USD | 73.75% |
| 2014 FY | -178.33 Thousand USD | 83.64% |
| 2014 Q2 | -64.42 Thousand USD | -13.38% |
| 2014 Q3 | -237.05 Thousand USD | -267.96% |
| 2013 Q3 | -169.76 Thousand USD | 53.97% |
| 2013 Q4 | -216.42 Thousand USD | -27.48% |
| 2013 FY | -1.08 Million USD | 57.72% |
| 2013 Q1 | -332.01 Thousand USD | 42.57% |
| 2013 Q2 | -368.83 Thousand USD | -11.09% |
| 2012 FY | -2.57 Million USD | 17.05% |
| 2012 Q2 | -823.17 Thousand USD | -51.26% |
| 2012 Q3 | -597.12 Thousand USD | 27.46% |
| 2012 Q4 | -578.07 Thousand USD | 3.19% |
| 2012 Q1 | -544.19 Thousand USD | 28.54% |
| 2011 FY | -3.1 Million USD | -1471.59% |
| 2011 Q4 | -761.55 Thousand USD | -24.63% |
| 2011 Q2 | -812.33 Thousand USD | 22.33% |
| 2011 Q1 | -1.04 Million USD | -1256.57% |
| 2011 Q3 | -611.06 Thousand USD | 24.78% |
| 2010 FY | -197.71 Thousand USD | -27.82% |
| 2010 Q4 | -77.1 Thousand USD | -58.04% |
| 2010 Q3 | -48.78 Thousand USD | -26.02% |
| 2010 Q2 | -38.71 Thousand USD | -18.49% |
| 2010 Q1 | -32.67 Thousand USD | -5.04% |
| 2009 Q1 | -37.37 Thousand USD | -100.61% |
| 2009 Q2 | -43.28 Thousand USD | -15.8% |
| 2009 Q3 | -32.41 Thousand USD | 25.11% |
| 2009 Q4 | -31.1 Thousand USD | 4.05% |
| 2009 FY | -154.68 Thousand USD | 54.57% |
| 2008 Q2 | -137.83 Thousand USD | -17.92% |
| 2008 Q3 | -6.26 Million USD | -4442.21% |
| 2008 FY | -340.52 Thousand USD | 70.72% |
| 2008 Q4 | 6.16 Million USD | 198.51% |
| 2008 Q1 | -116.88 Thousand USD | 84.9% |
| 2007 Q1 | -2091.71 USD | 85.71% |
| 2007 Q3 | -291.09 Thousand USD | -245.12% |
| 2007 Q4 | -774.26 Thousand USD | -165.98% |
| 2007 Q2 | -84.34 Thousand USD | -3932.37% |
| 2007 FY | -1.16 Million USD | -3632.9% |
| 2006 Q3 | -3013.61 USD | 52.13% |
| 2006 Q1 | -11.48 Thousand USD | -216.91% |
| 2006 FY | -31.15 Thousand USD | -22.82% |
| 2006 Q2 | -6296.00 USD | 45.2% |
| 2006 Q4 | -14.64 Thousand USD | -385.84% |
| 2005 Q4 | -3625.09 USD | 83.49% |
| 2005 Q3 | -21.95 Thousand USD | 0.0% |
| 2005 FY | -25.36 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -5.01 Million CAD | 95.614% |
| Asep Medical Holdings Inc | -7.72 Million CAD | 97.15% |
| BetterLife Pharma Inc. | -3.24 Million CAD | 93.208% |
| BioVaxys Technology Corp. | -2.4 Million CAD | 90.84% |
| ChitogenX Inc. | -2.83 Million CAD | 92.223% |
| Rapid Dose Therapeutics Corp. | -3.73 Million CAD | 94.114% |
| Defence Therapeutics Inc. | -12.65 Million CAD | 98.261% |
| Entheon Biomedical Corp. | -313.99 Thousand CAD | 29.91% |
| Gemina Laboratories Ltd. | -5.08 Million CAD | 95.673% |
| Glow Lifetech Corp. | -1.64 Million CAD | 86.603% |
| Lexston Life Sciences Corp. | -674.71 Thousand CAD | 67.382% |
| Pharmala Biotech Holdings Inc. | -762.95 Thousand CAD | 71.154% |
| Doseology Sciences Inc. | -377.63 Thousand CAD | 41.722% |
| MYND Life Sciences Inc. | -1.8 Million CAD | 87.826% |
| Nova Mentis Life Science Corp. | -1.2 Million CAD | 81.695% |
| PharmaTher Holdings Ltd. | -3.04 Million CAD | 92.77% |
| PreveCeutical Medical Inc. | -963.12 Thousand CAD | 77.15% |
| Telescope Innovations Corp. | -5.76 Million CAD | 96.184% |